Stock message boards
MNV
Market News Video
MNV MNV The 10 Most Popular Large-Caps in ETFs
MNV
MNV
MNV
MNV
MNV
MNV
MNV
Free Dividend Report - Top Ranked Stocks

Featured MNV Articles:

NPS Pharmaceuticals Inc. (NPSP) Shares Cross Above 200 DMA
Monday, May 5, 4:27 PM ET, by Market News Video Staff

In trading on Monday, shares of NPS Pharmaceuticals Inc. (NPSP) crossed above their 200 day ...

Short Interest Expands By 10.6% For HALO
Monday, May 12, 3:15 PM ET, by Market News Video Staff

The most recent short interest data has been released by the NASDAQ for the 04/30/2014 ...

Interesting HALO Put And Call Options For July 19th
Tuesday, May 20, 12:02 PM ET, by Market News Video Staff

Investors in Halozyme Therapeutics Inc (HALO) saw new options become available this week, for the ...

Halozyme Therapeutics Becomes Oversold (HALO)
Wednesday, May 21, 12:08 PM ET, by Market News Video Staff

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy ...

NPSP Makes Bullish Cross Above Critical Moving Average
Friday, May 30, 11:38 AM ET, by Market News Video Staff

In trading on Friday, shares of NPS Pharmaceuticals Inc. (NPSP) crossed above their 200 day ...

  More articles:  1 2 3 4 5 6 7 next »

INFI Crosses Below Key Moving Average Level

By Market News Video Staff, Tuesday, August 23, 11:56 AM ET
Play Video: Learn About The 200 DMA


If the video does not load after a few moments, Upgrade to the Latest Flash Player.

In trading on Tuesday, shares of Infinity Pharmaceuticals Inc (NASDAQ:INFI) crossed below their 200 day moving average of $6.60, changing hands as low as $6.50 per share. Infinity Pharmaceuticals Inc shares are currently trading up about 1.3% on the day. The chart below shows the one year performance of INFI shares, versus its 200 day moving average:

Infinity Pharmaceuticals Inc 200 Day Moving Average Chart

Looking at the chart above, INFI's low point in its 52 week range is $4.42 per share, with $10.42 as the 52 week high point that compares with a last trade of $6.99.

INFI operates in the Biotechnology sector, among companies like NPS Pharmaceuticals Inc. (NASDAQ:NPSP) which is up about 1.8% today, and Halozyme Therapeutics Inc (NASDAQ:HALO) trading up by about 1.4%. Below is a three month price history chart comparing the stock performance of INFI, versus NPSP and HALO.

INFI,NPSP,HALO Relative Performance Chart


Free Trial: ''ETF CHANNEL FLEXIBLE GROWTH INVESTMENT PORTFOLIO''

The ETF Channel Flexible Growth Investment Portfolio is designed to seek growth for investors anywhere and everywhere. The key to the program is our portfolio strategy allows us complete flexibility in terms of asset allocation as there are no predetermined guidelines as to the level of stocks, bonds, cash, regions, countries, sectors, commodities, or even asset classes in the portfolio! In short, this is a completely flexible portfolio designed to follow the performance trail wherever it leads us.


Top Six Most Viewed Stories This Week @ Market News Video:

This Article's Word Cloud:   Below   Call   Crossing   Definition   Earnings   Growth   HALO   Halozyme   INFI   Infinity   NPSP   Pharmaceuticals   Price   Rate   Start   Their   Therapeutics   Traded   Trial   about   allows   asset   average   below   changing   chart   commodities   currently   designed   flexibility   history   level   moving   performance   point   portfolio   program   raquo   regions   sector   sectors   share   shares   that   trading   versus   week   wherever   which   with
MNV
MNV
About Us - Advertise - Contact Us - Embedding Videos - Licensing Videos - Partners - mRSS / RSS Feed - Terms of Use - Privacy Policy - Video Widget
MNV
Home  |  Analyst News  Dividend Report  Econonomic News  Insider Report  Large Caps  Market Movers  Week Ahead Report  Weekly Market Wrap
MNV
MNV MNV Portfolio Channel Stock Market Definitions
MNV

INFI Crosses Below Key Moving Average Level | Market News Video | Copyright © 2008 - 2014, All Rights Reserved

Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners. In no way should any content contained herein be interpreted to represent trading or investment advice. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.